News
GSK expects to deliver annual sales and profit growth towards the top end of its forecasts after beating second-quarter ...
British drugmaker GSK said on Wednesday it is in talks with the Trump administration about ways to lower U.S. drug costs, ...
Shares of GSK PLC GSK slid 3.04% to £14.18 Thursday, on what proved to be an all-around rough trading session for the stock ...
GSK ( NYSE: GSK) CEO Emma Walmsley said on Wednesday that her company is in discussions with the Trump administration on how ...
Second-quarter sales rose to £7.99 billion from £7.88 billion in the same period the year prior.
GSK PLC GSK shares rose 4.69% to £14.63 Wednesday, on what proved to be an all-around favorable trading session for the stock ...
GSK Plc reported better-than-expected profit and raised its estimates for revenue at two key divisions in a report that ...
(Reuters) -British drugmaker GSK expects annual sales and profit to be towards the top of its forecast range, after ...
GlaxoSmithKline Pharmaceuticals to launch oncology assets Jemperli and Zejula in India, addressing critical unmet needs in ...
GSK tops Q2 estimates with growth in vaccines and specialty drugs, raises 2025 forecast amid progress in major late-stage ...
As you might know, GSK plc (LON:GSK) recently reported its interim numbers. GSK reported UK£16b in revenue, roughly in line ...
2d
Cyprus Mail on MSNGSK sets sights on £40bn sales by 2031 as US tariffs loom
GSK (GSK.L) expects to deliver annual sales and profit growth towards the top end of its forecasts after beating ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results